Fluorine in PDB 6j3c: Crystal Structure of Human Dhodh in Complex with Inhibitor 1291
Enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1291
All present enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1291:
1.3.5.2;
Protein crystallography data
The structure of Crystal Structure of Human Dhodh in Complex with Inhibitor 1291, PDB code: 6j3c
was solved by
Y.Yu,
Q.Chen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
40.93 /
1.85
|
Space group
|
P 32 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
90.596,
90.596,
122.803,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
16.9 /
19.5
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1291
(pdb code 6j3c). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the
Crystal Structure of Human Dhodh in Complex with Inhibitor 1291, PDB code: 6j3c:
Jump to Fluorine binding site number:
1;
2;
Fluorine binding site 1 out
of 2 in 6j3c
Go back to
Fluorine Binding Sites List in 6j3c
Fluorine binding site 1 out
of 2 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1291
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1291 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F407
b:21.6
occ:1.00
|
F17
|
A:B5X407
|
0.0
|
21.6
|
1.0
|
C15
|
A:B5X407
|
1.3
|
28.3
|
1.0
|
C16
|
A:B5X407
|
2.3
|
22.9
|
1.0
|
C14
|
A:B5X407
|
2.4
|
22.0
|
1.0
|
H161
|
A:B5X407
|
2.5
|
27.4
|
1.0
|
H191
|
A:B5X407
|
2.7
|
23.7
|
1.0
|
HD13
|
A:LEU46
|
2.8
|
44.6
|
1.0
|
C18
|
A:B5X407
|
2.8
|
21.1
|
1.0
|
C19
|
A:B5X407
|
3.0
|
19.7
|
1.0
|
HA
|
A:ALA59
|
3.4
|
19.3
|
1.0
|
HB2
|
A:ALA59
|
3.4
|
18.2
|
1.0
|
CD1
|
A:LEU46
|
3.5
|
37.2
|
1.0
|
C13
|
A:B5X407
|
3.6
|
23.2
|
1.0
|
HD23
|
A:LEU58
|
3.6
|
42.4
|
1.0
|
C11
|
A:B5X407
|
3.6
|
21.6
|
1.0
|
HD11
|
A:LEU46
|
3.6
|
44.6
|
1.0
|
HD12
|
A:LEU46
|
3.8
|
44.6
|
1.0
|
HE1
|
A:MET43
|
3.8
|
26.3
|
1.0
|
HB3
|
A:LEU58
|
3.8
|
23.9
|
1.0
|
C23
|
A:B5X407
|
3.9
|
18.0
|
1.0
|
CA
|
A:ALA59
|
4.0
|
16.1
|
1.0
|
N
|
A:ALA59
|
4.0
|
17.2
|
1.0
|
H
|
A:ALA59
|
4.0
|
20.6
|
1.0
|
C12
|
A:B5X407
|
4.1
|
18.7
|
1.0
|
CB
|
A:ALA59
|
4.1
|
15.2
|
1.0
|
C20
|
A:B5X407
|
4.1
|
24.1
|
1.0
|
HG
|
A:LEU58
|
4.2
|
44.6
|
1.0
|
O
|
A:ALA55
|
4.2
|
18.5
|
1.0
|
H231
|
A:B5X407
|
4.3
|
21.6
|
1.0
|
CD2
|
A:LEU58
|
4.5
|
35.3
|
1.0
|
HB1
|
A:ALA59
|
4.5
|
18.2
|
1.0
|
C
|
A:LEU58
|
4.6
|
17.1
|
1.0
|
HD22
|
A:LEU46
|
4.6
|
51.9
|
1.0
|
CB
|
A:LEU58
|
4.6
|
19.9
|
1.0
|
H253
|
A:B5X407
|
4.6
|
38.8
|
1.0
|
CG
|
A:LEU58
|
4.7
|
37.1
|
1.0
|
F27
|
A:B5X407
|
4.7
|
20.2
|
1.0
|
HB3
|
A:LEU46
|
4.7
|
39.1
|
1.0
|
N8
|
A:B5X407
|
4.7
|
22.1
|
1.0
|
H252
|
A:B5X407
|
4.7
|
38.8
|
1.0
|
CE
|
A:MET43
|
4.8
|
21.9
|
1.0
|
CG
|
A:LEU46
|
4.8
|
51.8
|
1.0
|
C22
|
A:B5X407
|
4.8
|
20.1
|
1.0
|
HB1
|
A:ALA55
|
4.8
|
23.3
|
1.0
|
HD21
|
A:LEU58
|
4.8
|
42.4
|
1.0
|
N24
|
A:B5X407
|
4.9
|
27.4
|
1.0
|
HB3
|
A:ALA59
|
4.9
|
18.2
|
1.0
|
C21
|
A:B5X407
|
4.9
|
19.0
|
1.0
|
O
|
A:LEU58
|
5.0
|
20.7
|
1.0
|
C25
|
A:B5X407
|
5.0
|
32.4
|
1.0
|
HB2
|
A:PHE62
|
5.0
|
30.0
|
1.0
|
HA
|
A:ALA55
|
5.0
|
17.1
|
1.0
|
|
Fluorine binding site 2 out
of 2 in 6j3c
Go back to
Fluorine Binding Sites List in 6j3c
Fluorine binding site 2 out
of 2 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1291
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1291 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F407
b:20.2
occ:1.00
|
F27
|
A:B5X407
|
0.0
|
20.2
|
1.0
|
C13
|
A:B5X407
|
1.3
|
23.2
|
1.0
|
C14
|
A:B5X407
|
2.3
|
22.0
|
1.0
|
C12
|
A:B5X407
|
2.4
|
18.7
|
1.0
|
H121
|
A:B5X407
|
2.6
|
22.4
|
1.0
|
HB3
|
A:LEU359
|
2.8
|
17.2
|
1.0
|
H231
|
A:B5X407
|
2.9
|
21.6
|
1.0
|
C18
|
A:B5X407
|
2.9
|
21.1
|
1.0
|
HD3
|
A:PRO364
|
2.9
|
24.0
|
1.0
|
C23
|
A:B5X407
|
3.1
|
18.0
|
1.0
|
HA2
|
A:GLY363
|
3.1
|
18.9
|
1.0
|
HD23
|
A:LEU359
|
3.3
|
19.4
|
1.0
|
O
|
A:LEU359
|
3.5
|
16.4
|
1.0
|
C15
|
A:B5X407
|
3.6
|
28.3
|
1.0
|
C11
|
A:B5X407
|
3.6
|
21.6
|
1.0
|
HB1
|
A:ALA59
|
3.7
|
18.2
|
1.0
|
CB
|
A:LEU359
|
3.8
|
14.4
|
1.0
|
HE1
|
A:MET43
|
3.9
|
26.3
|
1.0
|
CD
|
A:PRO364
|
3.9
|
20.0
|
1.0
|
HB2
|
A:ALA59
|
4.0
|
18.2
|
1.0
|
HE2
|
A:MET43
|
4.0
|
26.3
|
1.0
|
C19
|
A:B5X407
|
4.0
|
19.7
|
1.0
|
HD13
|
A:LEU359
|
4.0
|
18.4
|
1.0
|
HG3
|
A:PRO364
|
4.0
|
25.0
|
1.0
|
CA
|
A:GLY363
|
4.1
|
15.8
|
1.0
|
C16
|
A:B5X407
|
4.1
|
22.9
|
1.0
|
C
|
A:LEU359
|
4.1
|
19.5
|
1.0
|
CD2
|
A:LEU359
|
4.2
|
16.2
|
1.0
|
HB2
|
A:LEU359
|
4.3
|
17.2
|
1.0
|
C22
|
A:B5X407
|
4.3
|
20.1
|
1.0
|
CB
|
A:ALA59
|
4.3
|
15.2
|
1.0
|
H191
|
A:B5X407
|
4.3
|
23.7
|
1.0
|
CE
|
A:MET43
|
4.3
|
21.9
|
1.0
|
N
|
A:PRO364
|
4.4
|
13.8
|
1.0
|
CA
|
A:LEU359
|
4.4
|
16.0
|
1.0
|
CG
|
A:LEU359
|
4.4
|
11.6
|
1.0
|
HA
|
A:LEU359
|
4.4
|
19.2
|
1.0
|
HD21
|
A:LEU359
|
4.4
|
19.4
|
1.0
|
HA3
|
A:GLY363
|
4.4
|
18.9
|
1.0
|
CG
|
A:PRO364
|
4.5
|
20.8
|
1.0
|
C
|
A:GLY363
|
4.5
|
13.8
|
1.0
|
HD2
|
A:PRO364
|
4.5
|
24.0
|
1.0
|
HE1
|
A:PHE98
|
4.6
|
27.1
|
1.0
|
CD1
|
A:LEU359
|
4.7
|
15.3
|
1.0
|
F17
|
A:B5X407
|
4.7
|
21.6
|
1.0
|
HA
|
A:THR360
|
4.8
|
20.6
|
1.0
|
H
|
A:GLY363
|
4.8
|
21.7
|
1.0
|
N8
|
A:B5X407
|
4.8
|
22.1
|
1.0
|
H221
|
A:B5X407
|
4.9
|
24.1
|
1.0
|
HA
|
A:ALA59
|
4.9
|
19.3
|
1.0
|
HD22
|
A:LEU359
|
4.9
|
19.4
|
1.0
|
HG2
|
A:PRO364
|
5.0
|
25.0
|
1.0
|
C20
|
A:B5X407
|
5.0
|
24.1
|
1.0
|
HB3
|
A:ALA59
|
5.0
|
18.2
|
1.0
|
|
Reference:
T.Zeng,
Z.Zuo,
Y.Luo,
Y.Zhao,
Y.Yu,
Q.Chen.
A Novel Series of Human Dihydroorotate Dehydrogenase Inhibitors Discovered By in Vitro Screening: Inhibition Activity and Crystallographic Binding Mode. Febs Open Bio V. 9 1348 2019.
ISSN: ESSN 2211-5463
PubMed: 31087527
DOI: 10.1002/2211-5463.12658
Page generated: Thu Aug 1 21:28:29 2024
|